Brief: Bioarctic And Novartis Sign Option, Collaboration And License Agreement
Aug 26 (Reuters) - BioArctic AB BIOAb.ST: BIOARCTIC AND NOVARTIS SIGN AN OPTION, COLLABORATION AND LICENSE AGREEMENT USING BRAINTRANSPORTER™ FOR AN UPFRONT PAYMENT OF USD 30 MILLION PLUS ADDITIONAL POTENTIAL MILESTONES AND ROYALTIES Source text: ID:nWkr3V7dJg Further company coverage: [BIOAb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million